J. David Joyner's most recent trade in CVS Health Corp was a trade of 86,326 Common Stock (RSUs) done at an average price of $71.8 . Disclosure was reported to the exchange on March 31, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CVS Health | J. David Joyner | Director, President, CEO and Chair | Grant, award, or other acquisition of securities at price $ 71.82 per share. | 31 Mar 2026 | 86,326 | 160,860 | - | 71.8 | 6,199,933 | Common Stock (RSUs) |
| CVS Health | J. David Joyner | Director, President, CEO and Chair | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.49 per share. | 31 Mar 2026 | 8,029 | 70,349 (0%) | 0% | 72.5 | 582,022 | Common Stock |
| CVS Health | J. David Joyner | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.90 per share. | 28 Feb 2026 | 1,944 | 49,996 (0%) | 0% | 79.9 | 155,326 | Common Stock |
| CVS Health | J. David Joyner | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 226,138 | 226,138 | - | - | Stock Option | |
| CVS Health | J. David Joyner | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 53,324 | 82,515 | - | 0 | Common Stock (RSUs) | |
| CVS Health | J. David Joyner | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.98 per share. | 01 Apr 2025 | 1,847 | 51,940 (0%) | 0% | 68.0 | 125,559 | Common Stock |
| CVS Health | J. David Joyner | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.72 per share. | 28 Feb 2025 | 1,944 | 46,717 (0%) | 0% | 65.7 | 127,760 | Common Stock |
| CVS Health | J. David Joyner | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2024 | 1,492,537 | 1,492,537 | - | - | Premium Stock Option | |
| CVS Health | Joyner J. David | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2024 | 1,000,000 | 1,000,000 | - | - | Premium Stock Option | |
| CVS Health | Joyner J. David | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2024 | 492,537 | 492,537 | - | - | Premium Stock Appreciation Right | |
| CVS Health | J. David Joyner | EVP&President-PharmacyServices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 28,280 | 44,241 | - | 0 | Common Stock (Restricted) | |
| CVS Health | J. David Joyner | EVP&President-PharmacyServices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.19 per share. | 28 Feb 2024 | 1,970 | 40,681 (0%) | 0% | 75.2 | 148,124 | Common Stock |
| CVS Health | J. David Joyner | EVP&President-PharmacyServices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 51,959 | 51,959 | - | - | Stock Option | |
| CVS Health | J. David Joyner | EVP&President-PharmacyServices | Grant, award, or other acquisition of securities at price $ 83.54 per share. | 28 Feb 2023 | 23,940 | 23,940 | - | 83.5 | 1,999,948 | Common Stock (Restricted) |